Anavex Life Sciences
AVXL
#7514
Rank
S$0.52 B
Marketcap
S$5.62
Share price
1.83%
Change (1 day)
-49.20%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -S$61.69 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$65.26 Million a decrease over its 2023 earnings that were of -S$56.86 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$61.69 Million-5.47%
2024 -S$65.26 Million14.77%
2023 -S$56.86 Million-17.49%
2022 -S$68.91 Million22.96%
2021 -S$56.05 Million35.36%
2020 -S$41.41 Million12.65%
2019 -S$36.76 Million29.09%
2018 -S$28.47 Million36.33%
2017 -S$20.89 Million17.11%
2016 -S$17.84 Million20.91%
2015 -S$14.75 Million-6.29%
2014 -S$15.74 Million337.28%
2013 -S$3.6 Million
2008 -S$6.66 Million106.01%
2007 -S$3.24 Million8848.98%
2006 -S$0.04 Million-79.99%
2005 -S$0.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
S$84.54 M-242.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
S$82.99 M-240.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-S$6.07 Million-89.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-S$8.38 Million-85.86%๐Ÿ‡บ๐Ÿ‡ธ USA